1. Denijs FB, Van Poppel H, Stenzl A, et al. PSA testing in primary care: is it time to change our practice? BMC Prim Care. 2024;25(1):436. doi:10. 1186/s12875-024-02688-8
2. Benedict MOA, Steinberg WJ, Claassen FM, Mofolo N, van Rooyen C. Knowledge, attitude and practice on screening and early diagnosis of prostate cancer of primary health care providers in the Free State. African J Prim Health Care Family Med. 2023;15(1):a3688. doi:10.4102/phcfm.v15i1.3688
3. Czerw A, Deptala A, Glowacka M, et al. Prostate cancer-research advances in early detection. J Clin Med. 2025;14(9):3067. doi:10.3390/jcm14093067
4. Chai K, Xu C, Man J, Deng Y, Yang L. Evolving paradigms in prostate cancer screening: a decade of bibliometric insights and technological advancements. Front Oncol. 2025;15:1511880. doi:10.3389/fonc.2025. 1511880
5. Beltrán A, Parker L, Moral-Pérez I, et al. Impact of patients' age and comorbidities on prostate cancer overdiagnosis in clinical practice. Plos One. 2025;20(2)e0315979. doi:10.1371/journal.pone.0315979
6. Microsoft Corporation. (2016). Microsoft Excel (Version 2016). https://office.microsoft.com/excel
7. Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetrics. 2017;11(4):959-975. doi:10. 1016/j.joi.2017.08.007
8. RStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC; 2023. Available from: https://posit.co
9. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523-538. doi:10.1007/s11192-009-0146-3
10. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134. doi:10.7326/0003-4819-157-2-201207170-00459
11. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. The Lancet. 2014;384(9959):2027-2035. doi:10.1016/S0140-6736(14)60525-0
12. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419-426. doi:10.1016/j.juro.2013.04.119
13. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-1319. doi:10.1056/NEJMoa0810696
14. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European Study. New England J Med. 2009;360(13):1320-1328. doi:10.1056/NEJMoa0810084
15. Misra-Hebert AD, Hu B, Klein EA, et al. Prostate cancer screening practices in a large, integrated health system: 2007-2014. Bju Int. 2017; 120(2):257-264. doi:10.1111/bju.13793
16. Nguyen KD, Hyder ZZ, Shaw MD, et al. Effects of primary care physician density, urologist presence, and insurance status on stage of diagnosis for urologic malignancies. Cancer Epidemiol. 2018;52:10-14. doi:10.1016/j.canep.2017.10.012
17. Martin RM, Donovan JL, Turner EL, et al. Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality the CAP randomized clinical trial. Jama. 2018;319(9):883-895. doi:10.1001/jama.2018.0154
18. Young GJ, Harrison S, Turner EL, et al. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study. Bmj Open. 2017;7(10)e017729. doi:10.1136/bmjopen-2017-017729
19. Wawryk O, Collins IM, Lee A, et al. Rural variations in primary care prostate cancer diagnosis and survival: a cohort study using linked Australian primary care electronic medical record data. Bmc Cancer. 2025;25(1)1809. doi:10.1186/s12885-025-15044-5
20. Pickles K, Carter SM, Rychetnik L, McCaffery K, Entwistle VA. General practitioners' experiences of, and responses to, uncertainty in prostate cancer screening: insights from a qualitative study. Plos One. 2016;11(4)e0153299. doi:10.1371/journal.pone.0153299